NEW YORK, Dec. 11, 2025 /PRNewswire/ -- Today, the Lupus Research Alliance, the world's largest private funder of lupus research, announced the first recipients of the Mechanistic Clinical Award. This ...

Please provide your email address to receive an email when new articles are posted on . Patients with systemic lupus with a history of skin rashes are likely to have high interferon levels. This ...

The U.S. Food and Drug Administration (FDA) has approved Gazyva® (obinutuzumab), developed by Genentech, as a treatment for adults with lupus nephritis (LN), also known as lupus-related kidney disease ...

Margrit Wiesendanger, MD, PhD, discusses how lupus treatment is evolving from traditional therapies to more targeted options like biologics, with promising advances now being explored in clinical ...

Biogen announced positive results from the Phase 2 part of the AMETHYST Phase 2/3 study (part A) of investigational therapy, ...

A new study has shown that restoring the balance of a protein in blood may be a promising treatment option for systemic lupus erythematosus, or lupus, an incurable autoimmune disease. The protein, ...

Please provide your email address to receive an email when new articles are posted on . Victoria P. Werth, MD, professor of dermatology at the University of Pennsylvania Hospital, and chief of ...

Add Yahoo as a preferred source to see more of our stories on Google. Dealing with unexplained symptoms when you’re undergoing treatment for lupus can make you question what’s going on in your body.

With enpatoran soon entering Phase III clinical trials, the Phase II safety and efficacy results support the drug’s development.

Doctor after doctor misdiagnosed or shrugged off Ruth Wilson’s rashes, swelling, fevers, and severe pain for six years. She saved her life by begging for one more test in an emergency room about to ...

Living with lupus means navigating chronic inflammation that can show up nearly anywhere in your body, from your skin to your joints and kidneys. That can lead to uncomfortable and even debilitating ...